We are live on ! Find out more
PASG icon

Passage Bio
PASG

48 hedge funds and large institutions have $54.4M invested in Passage Bio in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,700% more call options, than puts

Call options by funds: $48K | Put options by funds: $1K

64% more capital invested

Capital invested by funds: $33.1M → $54.4M (+$21.3M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

0.64% more ownership

Funds ownership: 2.99% → 3.62% (+0.64%)

4% less funds holding

Funds holding: 50 → 48 (-2)

14% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 14

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders
48
Holders Change
-2
Holders Change %
-4%
% of All Funds
0.69%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
7
Increased
12
Reduced
14
Closed
9
Calls
$48K
Puts
$1K
Net Calls
+$47K
Net Calls Change
+$36K

Top Buyers

1
VPC
Vestal Point Capital
New York
+$5.41M
2
LCM
Lynx1 Capital Management
Puerto Rico
+$5.37M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$429K
4
AAA
Affinity Asset Advisors
New York
+$318K
5
FT
Fiduciary Trust
Massachusetts
+$120K

Top Sellers

1
TCM
Tang Capital Management
California
-$1.08M
2
EAM
Erste Asset Management
Austria
-$608K
3
PFCS
Pale Fire Capital SE
Czech Republic
-$529K
4
BlackRock
BlackRock
New York
-$120K
5
Citadel Advisors
Citadel Advisors
Florida
-$108K
Name Holding Trade Value Shares
Change 		Change in
Stake
DIM
26
DLK Investment Management
California
$86.4K – – –
XT
27
XTX Topco
Cayman Islands
$58K +$17.5K +727 +51%
Goldman Sachs
28
Goldman Sachs
New York
$36.4K +$72 +3 +0.2%
VF
29
Virtu Financial
New York
$34K -$50.9K -2,114 -62%
CAM
30
Cresset Asset Management
Illinois
$32K – – –
Marshall Wace
31
Marshall Wace
United Kingdom
$29.7K +$26.5K +1,100 New
HighTower Advisors
32
HighTower Advisors
Illinois
$29K -$602 -25 -2%
Fidelity Investments
33
Fidelity Investments
Massachusetts
$28.4K -$49.3K -2,047 -66%
Morgan Stanley
34
Morgan Stanley
New York
$18.7K -$16.6K -692 -50%
Barclays
35
Barclays
United Kingdom
$17.8K – – –
CSS
36
Cubist Systematic Strategies
Connecticut
$15.2K +$13.6K +565 New
Citigroup
37
Citigroup
New York
$5.36K -$1.01K -42 -18%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$1.06K – – –
Federated Hermes
39
Federated Hermes
Pennsylvania
$1.06K +$938 +39 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$1K +$144 +6 +32%
Wells Fargo
41
Wells Fargo
California
$417 – – –
JP Morgan Chase
42
JP Morgan Chase
New York
$369 -$1.32K -55 -80%
LI
43
LRI Investments
Florida
$304 +$265 +11 New
Osaic Holdings
44
Osaic Holdings
Arizona
$293 – – –
Group One Trading
45
Group One Trading
Illinois
$63 – – –
TRCT
46
Tower Research Capital (TRC)
New York
$46 +$48 +2 New
FDCDDQ
47
Federation des caisses Desjardins du Quebec
Quebec, Canada
$14 -$6.01K -250 -100%
Qube Research & Technologies (QRT)
48
Qube Research & Technologies (QRT)
United Kingdom
$5 – – –
Bank of America
49
Bank of America
North Carolina
$1 -$48 -2 Closed
WMSA
50
Weiss Multi-Strategy Advisers
New York
– -$245K -12,145 Closed
1
2
3

PASG Hedge Fund Activity: Q1 2024 in Review

48 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q1 2024, worth a combined $54.4M — up 64% from $33.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of PASG and 7 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 12 added.

The largest buyer was Vestal Point Capital, opening a new position worth an estimated $5.41M. The largest seller was Tang Capital Management, cutting an estimated $1.08M.

  • 48 institutional investors held Passage Bio (PASG) as of Q1 2024, down from 50 in Q4 2023.
  • Funds reported $54.4M of Passage Bio stock for Q1 2024, up 64% quarter-over-quarter.
  • 7 funds opened new Passage Bio positions in Q1 2024 and 9 closed out, a net change of -2 holders.
  • The largest Passage Bio buyer in Q1 2024 was Vestal Point Capital, an estimated $5.41M added.
  • The largest Passage Bio seller in Q1 2024 was Tang Capital Management, an estimated $1.08M sold.

Based on aggregated 13F filings for Q1 2024.